APA (7th ed.) Citation

Yang, H., Ma, D., Liu, Y., Hu, X., Zhang, J., Wang, Z., . . . Shao, Z. (2018). Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer. Scientific Reports, 8(1), 1. https://doi.org/10.1038/s41598-018-32881-6

Chicago Style (17th ed.) Citation

Yang, Hai-Yuan, Ding Ma, Yi-Rong Liu, Xin Hu, Jian Zhang, Zhong-Hua Wang, Gen-Hong Di, Xi-Chun Hu, and Zhi-Ming Shao. "Author Correction: Impact of Hormone Receptor Status and Distant Recurrence-free Interval on Survival Benefits from Trastuzumab in HER2-positive Metastatic Breast Cancer." Scientific Reports 8, no. 1 (2018): 1. https://doi.org/10.1038/s41598-018-32881-6.

MLA (9th ed.) Citation

Yang, Hai-Yuan, et al. "Author Correction: Impact of Hormone Receptor Status and Distant Recurrence-free Interval on Survival Benefits from Trastuzumab in HER2-positive Metastatic Breast Cancer." Scientific Reports, vol. 8, no. 1, 2018, p. 1, https://doi.org/10.1038/s41598-018-32881-6.